Quick Answer
PTC THERAPEUTICS, INC. reported Diluted EPS of $7.78 per share for fiscal year 2025.
PTC THERAPEUTICS, INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $7.78 | +264.5% |
| 2024 | -$4.73 | +43.5% |
| 2023 | -$8.37 | -7.4% |
| 2022 | -$7.79 | -4.8% |
| 2021 | -$7.43 | -11.9% |
| 2020 | -$6.64 | -55.5% |
| 2019 | -$4.27 | -43.8% |
| 2014 | -$2.97 | +42.7% |
| 2013 | -$5.18 | -112.2% |
| 2012 | $42.50 | +834.1% |
| 2011 | $4.55 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.20 | +114.4% | +124.1% |
| June 30, 2025 | -$0.83 | +35.7% | -108.3% |
| March 31, 2025 | $10.04 | +936.7% | +822.3% |
| September 30, 2024 | -$1.39 | +21.0% | -7.8% |
| June 30, 2024 | -$1.29 | +51.5% | -7.5% |
| March 31, 2024 | -$1.20 | +36.2% | +31.8% |
| September 30, 2023 | -$1.76 | -15.0% | +33.8% |
| June 30, 2023 | -$2.66 | -24.9% | -41.5% |
- PTC THERAPEUTICS, INC. showed an increase of +264.5% in Diluted EPS compared to the prior fiscal year.
- Over the 2011–2025 period, PTC THERAPEUTICS, INC.’s diluted eps has grown by 71.0% (from $4.55 per share to $7.78 per share).
- The most recent figure is from PTC THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: